75 Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis

75 Comparative Effectiveness and Safety of Direct Oral Anticoagulants Compared with Warfarin in Patients with Low Bodyweight who have Atrial Fibrillation: A Systematic Review and Meta-analysis

Saved in:

Bibliographic Details
Main Authors:	Mohamed Elshafei, Ahmed El-Bardissy, Muhammad Salem, Mohamed Abdelmoneim, Mohammed Danjuma
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Research and Practice in Thrombosis and Haemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475037925000937
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Direct Oral Anticoagulants Compared to Warfarin in Patients with Intermediate‐ to High‐Risk Pulmonary Embolism: A Systematic Review and Meta‐Analysis
by: Mohamed Nabil Elshafei, et al.
Published: (2025-06-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
by: Ghadeer K. Dawwas, et al.
Published: (2025-02-01)

Direct oral anticoagulants vs warfarin in patients with inflammatory bowel disease and atrial fibrillation: a comparative analysis of efficacy and safety
by: Ayoyimika Okunlola, et al.
Published: (2025-07-01)

The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation
by: Ya. M. Mykhailovskyi
Published: (2022-06-01)

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)
by: Ma Carmen Montero-Balosa, et al.
Published: (2025-08-01)

Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
by: E. S. Mazur, et al.
Published: (2021-11-01)

174 Peri-Procedural Warfarin Bridging Evaluation for Patients with Atrial Fibrillation Enrolled in an Anticoagulation Management Service
by: Hamza H. Sinan, et al.
Published: (2025-05-01)

Efficacy and Safety of New Oral Anticoagulants versus Warfarin in the Resolution of Atrial Fibrillation with Left Atrial/Left Atrial Appendage Thrombus: A Systematic Review and Meta-Analysis
by: Guan-lian Mo, et al.
Published: (2025-01-01)

Fibrilação atrial crônica, AVC e anticoagulação: sub-uso de warfarina ? Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?
by: Norberto L. Cabral, et al.
Published: (2004-12-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Comparing rates of clinically relevant epistaxis in patients taking warfarin versus direct oral anticoagulants
by: Khristian S. Burke, et al.
Published: (2024-11-01)

COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION
by: A. V. Rudakova, et al.
Published: (2015-09-01)

Comparison between DOACs and warfarin for left atrial thrombus in atrial fibrillation patients
by: Akihiro Sunaga, et al.
Published: (2025-08-01)

Evaluating Acute Ischemic Strokes despite Regular Anticoagulation: A Comparative Analysis of Direct Oral Anticoagulants and Warfarin in Treatment Outcomes
by: Sumeyye Cakmak, et al.
Published: (2024-01-01)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

Left Atrial Appendage Closure Compared With Oral Anticoagulants for Patients With Atrial Fibrillation: A Systematic Review and Network Meta‐Analysis
by: Angelo Oliva, et al.
Published: (2024-08-01)

Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study
by: Maha A.T. Elsebaie, et al.
Published: (2025-05-01)

Factors related to the choice of warfarin for treating newly diagnosed nonvalvular atrial fibrillation are associated with safety outcomes during anticoagulation: A new‐user, active‐comparator, retrospective cohort study
by: Yoshiko Takagi, et al.
Published: (2024-12-01)

Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable
by: D. A. Napalkov, et al.
Published: (2018-11-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
by: Jean Michell Correia Monteiro, et al.

Renal function decline in Asian patients with atrial fibrillation with warfarin and non‐vitamin K antagonist oral anticoagulants: A report from the COOL‐AF registry
by: Rungroj Krittayaphong, et al.
Published: (2025-04-01)

The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation
by: A. N. Turov, et al.
Published: (2020-03-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Djishambaev, et al.
Published: (2020-12-01)

New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model
by: Yan Li, et al.
Published: (2019-12-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

PO57 | Direct oral anticoagulant determination in urine samples compared to plasma concentrations in outpatients with atrial fibrillation and obesity
Published: (2025-08-01)

Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.
by: Giorgio Ciminata, et al.
Published: (2022-01-01)

Clinical outcomes in recently diagnosed atrial fibrillation related to mitral stenosis compared to non-valvular atrial fibrillation
by: Mohamed Aboelhassan, et al.
Published: (2025-06-01)

WARFARIN: PLACE IN THE ANTICOAGULANT THERAPY TODAY
by: N. A. Novikova, et al.
Published: (2016-07-01)

Meta-analysis comparing apixaban versus warfarin anticoagulation therapies for patients with severe renal insufficiency
by: LIANG Qiao-jing, et al.
Published: (2019-01-01)

TIME IN THERAPEUTIC RANGE (TTR) IN ATRIAL FIBRILLATION WITH WARFARIN THERAPY IN SEMARANG, INDONESIA
by: Della Dafina Sekarsari, et al.
Published: (2021-10-01)

Is there still room for warfarin after the appearance of direct oral anticoagulants?
by: E. P. Panchenko
Published: (2023-01-01)

Efficacy and safety of non‐vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation and kidney failure under hemodialysis: A meta‐analysis of controlled randomized trials
by: Ting‐Yung Chang, et al.
Published: (2025-06-01)

Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
by: Pasquale Santangeli, et al.
Published: (2011-01-01)

Renal Outcomes of Novel Oral Anticoagulants Among Patients With Atrial Fibrillation
by: Yik Ching Hung, et al.
Published: (2025-06-01)